Research Projects
Translational drug allergy - reshaping the approach to allergy delabelling


Programme(s) to which this project applies:

☑ MPhil/PhD ☑MRes[Med] ☑ URIS

Objective and Significance:

  • To study comparative epidemiology of drug allergy labels and genuine allergy labels across different populations 
  • Devise and investigate novel strategies in delabelling incorrect drug allergies
  • Investigate the impact of delabelling incorrect drug allergies (especially penicillin) on healthcare resources and antimicrobial stewardship

Research Plan and Methodology:
Cross-sectional and prospective clinical studies in patients labelled with drug allergy, investigating the longitudinal impacts of delabelling

Professor PH Li, Department of Medicine

Professor Philip Li was the first locally trained Specialist in Immunology & Allergy in Hong Kong and currently serves as a Clinical Assistant Professor at the University of Hong Kong (HKU). He is also Division Chief of Rheumatology & Clinical Immunology at both HKU and HKU-Shenzhen Hospital. Additionally, he is the President of the Hong Kong Institute of Allergy, Board Director of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) and Secretary of the International Societies Council of the European Academy of Allergy and Clinical Immunology (EAACI).

Prof Li has special interests in drug allergy, immunodeficiency and urticaria/angioedema. Notably, he established Hong Kong’s first specialist Immunology & Allergy training centre and leads the territory-wide Drug Allergy Delabelling Initiative (HK-DADI). As head of the Immunology & Allergy services of the Hong Kong West Cluster/HKU, he has steered the institution towards accreditation as both an Urticaria and Angioedema Centre of Reference & Excellence, as well as both a World Allergy Organization and APAAACI Centre of Excellence. He is also the Chairperson of the APAAACI Drug Allergy Committee.

Prof Li's influence is clearly demonstrated through his significant contributions to various local and international guidelines. These include guidelines on chronic urticaria, hereditary angioedema, and his role as the lead author of the clinical pathway for penicillin allergy testing in the Asia Pacific region. He has authored over 200 peer-reviewed articles in the disciplines of allergy, immunology, and autoimmunity. Additionally, he lends his expertise to Editorial Boards of several international journals including Vaccine, Frontiers in Immunology, Asian Pacific Journal of Allergy and Immunology and Asia Pacific Allergy.

Biography
 HKU Scholars Hub
Lab Homepage
ORCID
liphilip@hku.hk

For more information or to express interest for this project, please email the supervisor or the specified contact point in the project description.  Interested candidates are advised to enclose with your email:

  1. your CV,
  2. a brief description of your research interest and experience, and
  3. two reference letters (not required for HKUMed UG students seeking MRes[Med]/URIS projects).

Information on the research programme, funding support and admission documentations could be referenced online at the Research Postgraduate Admissions website. General admission enquiries should be directed to rpgmed@hku.hk.

HKUMed MBBS students interested in the Master of Research in Medicine (MRes[Med]) programme may visit the programme website for more information.  

HKUMed UG students interested in the Undergraduate Research Internship Scheme (URIS) may visit the scheme’s website for more information.